National and international developments in cancer, health and policy. Produced in collaboration with the Press Association unless otherwise stated.
A targeted combination treatment for patients with a specific type of blood cancer will soon be available on the NHS in Scotland.
A targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.
US researchers have found a link between the makeup of bacteria in the tumours of people with pancreatic cancer and how long they live.
Combining an immunotherapy with chemotherapy has been recommended as a treatment for some patients with lung cancer on the NHS in England.
Taking a daily aspirin for more than two years could reduce the risk of bowel cancer in people with Lynch syndrome, according to new draft guidance from NICE.